Xenetic Biosciences, Inc(NASDAQ:XBIO) 
Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and oncology therapeutics....
Website: http://www.xeneticbio.com
Founded: 1997
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.53
H 2.53
L 2.46
C 2.46
V 2,436
10EMA 2.46
20EMA 2.46
60EMA 2.46
120EMA 2.46
250EMA 2.46